Jeffrey W. Moses, MD

Our colleague and cath lab expert, Dr. Barry Uretsky from the University of Arkansas, Little Rock, started this conversation with one of the oldest and probably most important questions about coronary angiography, and that is, how should we...

Our colleague and cath lab...

01/06/2016

Cath Lab Digest

Acute Angiographic and Clinical Results of the NIR w/SOX Stent

08/01/2008

Roxana Mehran , MD;

Jeffrey W. Moses , MD;

Michael B. Collins , MD;

Edward M. Kreps , MD;

Milena Adamian , MD;

Issam Moussa , MD;

Yoshio Kobayashi , MD;

Kartik Desai , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Martin B. Leon , MD;

George D. Dangas , MD, PhD;

Lower restenosis rates were shown in selected lesions with the first-generation Palmaz-Schatz stent when compared to conventional balloon angioplasty.1 However, because the Palmaz-Schatz stent and its delivery system were rigid, stent...

Lower restenosis rates were...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

Who Should Get the Consent for Cardiac Cath in Your Lab?

03/02/2018

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Charles E. Chambers , MD;

Jeffrey W. Moses , MD;

Andrew D. Michaels , MD, MAS;

Jim Blankenship , MD;

Lloyd W. Klein , MD;

One of our colleagues, Andrew Michaels, MD, Director of the Cardiac Catheterization Laboratory at St. Joseph Hospital in Eureka, California, recently asked about the consent process for cardiac cath cases.

One of our colleagues, Andrew...

03/02/2018

Cath Lab Digest

Original Contribution

Treatment of Restenotic Drug-Eluting Stents: An Intravascular
Ultrasound Analysis

08/01/2008

Koichi Sano , MD, PhD;

Stephane G. Carlier , MD, PhD;

Emilia Solinas , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Jie Qian , MD;

Gary S. Mintz , MD;

Eduardo Missel , MD;

Martin B. Leon , MD;

Roxana Mehran , MD;

Shoujie Shan , MD;

Alexandra J. Lansky , MD;

Jeffrey W. Moses , MD;

Theresa Franklin-Bond , MS, PA;

George D. Dangas , MD, PhD;

Giora Weisz , MD;

Paul Boland , BS;

Michael B. Collins , MD;

Nobuhiko Fujita , MD;

Edward M. Kreps , MD;

Issam Moussa , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...

Sirolimus-eluting and...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Robotic-Enhanced PCI Compared to the Traditional Manual Approach

07/08/2014

Kate E. Dalton , MS;

Nathaniel R. Smilowitz , MD, MS;

Lauren T. Privitera , MPH;

Diane Canone-Weber , MPH;

Jeffrey W. Moses , MD;

Giora Weisz , MD;

Varinder Singh , MD;

Martin B. Leon , MD;

Fernando A. Sosa , BA;

Benjamin Lerman , BA;

Yasir Qureshi , MD;

Remote-controlled robotic-enhanced percutaneous coronary intervention (PCI) was developed to improve procedural outcomes, reduce operator radiation exposure, and improve ergonomics. Critics questioned whether protection of the operator might...

Remote-controlled...

07/08/2014

Journal of Invasive Cardiology

Original Contribution

Temporal Trends in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry

03/20/2020

Emad Hakemi , MD;

Santiago Garcia , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

M. Nicholas Burke , MD;

Subhash Banerjee , MD, FSCAI;

Khaldoon Alaswad , MD;

Fotios Gkargkoulas , MD;

Shuaib M. Abdullah , MD;

Iosif Xenogiannis , MD;

Dimitrios Karmpaliotis , MD, PhD;

Allison Hall , MD;

Farouc A. Jaffer , MD, PhD;

Robert W. Yeh , MD, MBA, MSc;

Nicholas J. Lembo , MD;

Anthony H. Doing , MD;

Jeffrey W. Moses , MD;

Catalin Toma , MD;

Ziad A. Ali , MD, DPhil;

James W. Choi , MD;

Manish A. Parikh , MD;

Oleg Krestyaninov , MD;

Aris Karatasakis , MD;

Ehtisham Mahmud , MD;

Dmitrii Khelimskii , MD;

Barbara Anna Danek , MD;

Mitul P. Patel , MD;

Philip Dattilo , MD;

Bavana V. Rangan , BDS, MPH, MD;

Evangelia Vemmou , MD;

Ajay J. Kirtane , MD, SM;

Juan Russo , MD;

Ilias Nikolakopoulos , MD;

Barry F. Uretsky , MD;

Abstract: Background. Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has significantly evolved in recent years. Methods. We compared the clinical, angiographic, and technical characteristics, as well as procedural...

Abstract: Background. Chronic...

03/20/2020

Journal of Invasive Cardiology

Systemic Anaphylactoid Reactions to Iodinated Contrast Media During Cardiac Catheterization Procedures:Guidelines for preventi

06/19/2008

Jerome E. Goss , MD;

Charles E. Chambers , MD;

Frederick A. Heupler , MD;

Jeffrey W. Moses , MD;

Arfan J. Al-Hani , MD;

William T. Armstrong , MD;

Airlie A.C. Cameron , MD;

Wayne E. Dear , MD;

Stephen Balter , PhD;

Manuel de la Llata , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

John P. Dervan , MD;

James C. Dillion , MD;

Lowell I. Gerber , MD;

Kenneth R. Jutzy , MD;

Francis Y.K. Lau , MD;

William J. Phillips , MD;

Sheldon S. Sbar , MD;

William C. Sheldon , MD;

Neal S. Kleiman , MD;

This report represents the first guidelines for prevention, diagnosis, and treatment of anaphylactoid reactions to contrast media occurring specifically during cardiac catheterization. The incidence of contrast media complications in the...

This report represents the first...

06/19/2008

Cath Lab Digest

Clinical Editor's Corner

“Let the Patient Eat.” Isn’t It Time to Change the NPO Rule for the Cath Lab?

01/31/2016

Arnold H. Seto , MD, MPA, CCDS, FACC, FSCAI;

Jeffrey W. Moses , MD;

Samuel M. Butman , MD;

Allen Jeremias , MD, MSc;

Kirk N. Garrett ;

Pinak Bipin Shah ;

John Bittl , MD;

James C. Blankenship , MD;

Sunil V. Rao , MD, FACC, FSCAI;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

What is the rationale for continuing the NPO order

What is the rationale for...

01/31/2016

Cath Lab Digest

Original Contribution

Initial Clinical Experience Using an Ostial Stent Positioning System (Ostial Pro‚Ñ¢) for the Accurate Placement of Stents in the

02/10/2009

Jeffrey W. Moses , MD;

From Borgess Heart Institute, Kalamazoo, Michigan; §Heart & Vascular Adventist Midwest Health, Lagrange, Illinois; †Baptist Hospital, Knoxville, Tennessee; √Weill Cornell Medical College, New York Hospital, New York, New York; *Columbia...

From Borgess Heart Institute,...

02/10/2009

Journal of Invasive Cardiology

Original Contribution

Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry

02/25/2018

Khaldoon Alaswad , MD;

Dimitrios Karmpaliotis , MD, PhD;

Farouc A. Jaffer , MD, PhD;

Robert W. Yeh , MD, MBA, MSc;

Michael R. Wyman , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Nicholas J. Lembo , MD;

Jeffrey W. Moses , MD;

Subhash Banerjee , MD, FSCAI;

Anthony H. Doing , MD;

Ziad A. Ali , MD, DPhil;

David E. Kandzari , MD;

Craig A. Thompson , MD, MMSc;

Manish A. Parikh , MD;

William W. O'Neill , MD;

Catalin Toma , MD;

Aris Karatasakis , MD;

James W. Choi , MD;

Barbara Anna Danek , MD;

Mir Babar Basir , MD, DO;

Judit Karacsonyi , MD, PhD;

Mohammad Alqarqaz , MD;

Bavana V. Rangan , BDS, MPH, MD;

Ajay J. Kirtane , MD, SM;

Ehtisham Mahmud , MD;

William L. Lombardi , MD;

Mitul P. Patel , MD;

Santiago Garcia , MD;

We examined the characteristics and outcomes of 1598 CTO-PCIs. Despite more complex clinical and angiographic characteristics, we found that elective use of mechanical circulatory support (MCS) in high-risk patients was associated with...

We examined the characteristics...

02/25/2018

Journal of Invasive Cardiology